Biotech Catches Eye of Bill Gates

For chief executives of startup biotechnology companies, traveling hat-in-hand to investor conferences in pursuit of new financing is an unrelenting task.

So it was a particularly good day for Michael Pellini, CEO of Foundation Medicine Inc., when an unsolicited query from Bill Gates popped up in his inbox last September.

The co-founder of Microsoft Corp. and global-health philanthropist had heard about Foundation’s new cancer diagnostic test and wanted more information about the company. The email didn’t mention any interest in investing in Foundation, and Dr. Pellini wasn’t actually looking for money—the company was poised to announce it had closed on a new round of financing. But Dr. Pellini wasted no time in responding.
Read the rest of this post on the original site »


Must-Reads from other Web sites

Megan Miller

Myspace and Urban Renewal

Om Malik and Stacey Higginbotham

Having Problems With Your Netflix? You Can Blame Verizon.

Tony Haile

If the Pageview Is Dead, Now What?

Alistair Barr

From the Ashes of Webvan, Amazon Builds a Grocery Business

Graeme Wood

Scrubbed

About Voices

Along with original content and posts from across the Dow Jones network, this section of AllThingsD includes Must-Reads From Other Web Sites — pieces we’ve read, discussions we’ve followed, stuff we like. Six posts from external sites are included here each weekday, but we only run the headlines. We link to the original sites for the rest. These posts are explicitly labeled, so it’s clear that the content comes from other Web sites, and for clarity’s sake, all outside posts run against a pink background.

We also solicit original full-length posts and accept some unsolicited submissions.

Voices is edited by Beth Callaghan.

Partner Advertisement

VentureBeat